Vascular Access Choice, Complications, and Outcomes in Children on Maintenance Hemodialysis: Findings From the International Pediatric Hemodialysis Network (IPHN) Registry.

Pediatric dialysis access dysfunction access infection access revision adolescents arteriovenous fistula (AVF) arteriovenous graft (AVG) central venous catheter (CVC) children end-stage renal disease (ESRD) long-term hemodialysis registry data vascular access

Journal

American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075

Informations de publication

Date de publication:
08 2019
Historique:
received: 29 04 2018
accepted: 12 02 2019
pubmed: 24 4 2019
medline: 19 3 2020
entrez: 24 4 2019
Statut: ppublish

Résumé

Arteriovenous fistulas (AVFs) have been recommended as the preferred vascular access for pediatric patients on maintenance hemodialysis (HD), but data comparing AVFs with other access types are scant. We studied vascular access choice, placement, complications, and outcomes in children. Prospective observational cohort study. 552 children and adolescents from 27 countries on maintenance HD followed up prospectively by the International Pediatric HD Network (IPHN) Registry between 2012 and 2017. Type of vascular access: AVF, central venous catheter (CVC), or arteriovenous graft. Infectious and noninfectious vascular access complication rates, dialysis performance, biochemical and hematologic parameters, and clinical outcomes. Univariate and multivariable linear mixed models, generalized linear mixed models, and proportional hazards models; cumulative incidence functions. During 314 cumulative patient-years, 628 CVCs, 225 AVFs, and 17 arteriovenous grafts were placed. One-third of the children with an AVF required a temporary CVC until fistula maturation. Vascular access choice was associated with age and expectations for early transplantation. There was a 3-fold higher living related transplantation rate and lower median time to transplantation of 14 (IQR, 6-23) versus 20 (IQR, 14-36) months with CVCs compared with AVFs. Higher blood flow rates and Kt/V Clinical rather than population-based data. CVCs are the predominant vascular access choice in children receiving HD within the IPHN. Age-related anatomical limitations and expected early living related transplantation were associated with CVC use. CVCs were associated with poorer dialysis efficacy, higher complication rates, and more frequent need for vascular access replacement. Such findings call for a re-evaluation of pediatric CVC use and practices.

Identifiants

pubmed: 31010601
pii: S0272-6386(19)30616-X
doi: 10.1053/j.ajkd.2019.02.014
pii:
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

193-202

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Dagmara Borzych-Duzalka (D)

Department of Pediatrics, Nephrology and Hypertension, Medical University of Gdansk, Gdansk, Poland.

Rukshana Shroff (R)

Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.

Gema Ariceta (G)

Hospital Universitario Materno-Infantil Vall D Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.

Yok-Chin Yap (YC)

Kuala Lumpur Hospital, Kuala Lumpur, Malaysia.

Fabio Paglialonga (F)

Pediatric Nephrology, Dialysis, and Transplant Unit, Fondazione IRCCS Ca' Granda, Osp. Maggiore Policlinico, Milano, Italy.

Hong Xu (H)

Fundan University, Shanghai, China.

Hee Gyung Kang (HG)

Kidney Center for Children and Adolescents, Seoul, Korea.

Julia Thumfart (J)

Charité, Virchow Klinikum, Berlin, Germany.

Karabay Bayazit Aysun (KB)

Department of Pediatric Nephrology, Cukurova University, Faculty of Medicine, Adana, Turkey.

Constantinos J Stefanidis (CJ)

Mitera Children's Hospital, Athens, Greece.

Marc Fila (M)

Pediatric Nephrology Unit, CHU Arnaud de Villeneuve-Université de Montpellier, Montpellier, France.

Lale Sever (L)

Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey.

Karel Vondrak (K)

University Hospital Motol, Prague, Czech Republic.

Attila J Szabo (AJ)

MTA-SE Pediatric and Nephrology Research Group, Budapest, Hungary.

Maria Szczepanska (M)

Department of Pediatrics, SMDZ in Zabrze, SUM in Katowice, Poland.

Bruno Ranchin (B)

Hôpital Femme Mere Enfant, Hospices Civils de Lyon, Lyon, France.

Tuula Holtta (T)

Children's Hospital, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.

Ariane Zaloszyc (A)

Children's Dialysis Center, Strasbourg, France.

Ilmay Bilge (I)

Istanbul University Medical Faculty; Koc University, School of Medicine, Istanbul, Turkey.

Bradley A Warady (BA)

Children's Mercy Hospital, Kansas City, KS.

Franz Schaefer (F)

Center for Pediatrics and Adolescent Medicine, Heidelberg, Germany.

Claus Peter Schmitt (CP)

Center for Pediatrics and Adolescent Medicine, Heidelberg, Germany. Electronic address: claus.peter.schmitt@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH